Latest News and Press Releases
Want to stay updated on the latest news?
-
BERLIN, Germany, Jan. 8, 2002 (PRIMEZONE) -- atugen AG announced today that it has signed a collaboration agreement with Novo Nordisk A/S to validate novel genetic targets associated with diabetes...
-
MARTINSRIED/MUNICH, Germany and BOSTON, Nov. 26, 2001 (PRIMEZONE) -- GPC Biotech AG (Frankfurt Stock Exchange:GPC) announced the signing of a development and manufacturing agreement with ICOS...
-
MARTINSRIED, Germany, Oct. 8, 2001 (PRIMEZONE) -- Munich-based Ingenium Pharmaceuticals AG has opened a subsidiary in Boston and expanded its international business development activities by...
-
LAUSANNE, Switzerland, August 6, 2001 (PRIMEZONE) -- Modex Therapeutics Ltd. (SWX New Market:MDXN) announced today that it has signed a second agreement with Serono S.A. (SWX:SEO) (NSYE:SRA) for the...
-
LAUSANNE, Switzerland, August 6, 2001 (PRIMEZONE) -- Modex Therapeutics Ltd. (SWX New Market:MDXN) today announced its financial results for the second quarter ended June 30, 2001. Income Income...
-
CAMBRIDGE, UK, July 3, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) announced today that it has acquired Management Dynamics Cambridge (MDC) - a specialist organizational...
-
LONDON, May 22, 2001 (PRIMEZONE) - Noonan/Russo Ltd. Cambridge Drug Discovery Limited (Cambridge Drug Discovery) and Millennium Pharmaceuticals, Inc. (Nasdaq:MLNM) today announced that they have...
-
LONDON, May 22, 2001 (PRIMEZONE) -- Cambridge Drug Discovery Limited (Cambridge Drug Discovery) and Teijin Limited (Teijin), today announced that they have entered into a key collaborative agreement...
-
CAMBRIDGE, U.K., May 9, 2001 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, and the Daresbury Analytical Research and Technology Service (DARTS) today announced the...
-
LONDON, May 4, 2001 (PRIMEZONE) - Noonan/Russo - - WEBCAST EVENT- - Noonan/Russo's BioInvestor Forum Friday 5 May 2001 from 15:00 BST www.noonanrusso.com With presentations from: OXiGENE...